CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results Noninvasive Nuclear SPECT Myocardial Blood Flow Quantitation to Guide Management for Coronary Artery Disease Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension Nitrosative stress drives heart failure with preserved ejection fraction

Clinical TrialNov 06, 2021.

JOURNAL:J Am Coll Cardiol Intv. Article Link

Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

F Zahr , HK Song , SM Chadderdon et al. Keywords: TMVR; early feasibility study; 30-day outcome

Full Text PDF